Cargando…
A critical analysis of barriers to the clinical implementation of pharmacogenomics
Over recent decades, basic research has yielded a large volume of data on many potentially clinically relevant genetic determinants of drug efficacy and toxicity. Until recently, most examples involved genes encoding drug-metabolizing enzymes, particularly the cytochromes P450. More recently, rapid...
Autores principales: | McKinnon, Ross A, Ward, Michael B, Sorich, Michael J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376080/ https://www.ncbi.nlm.nih.gov/pubmed/18473000 |
Ejemplares similares
-
Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis
por: Virelli, Catherine R., et al.
Publicado: (2021) -
Scientific Challenges and Implementation Barriers to Translation of Pharmacogenomics in Clinical Practice
por: Lam, Y. W. Francis
Publicado: (2013) -
Predictors of Long-Term Disease Control and Survival for HER2-Positive Advanced Breast Cancer Patients Treated With Pertuzumab, Trastuzumab, and Docetaxel
por: Hopkins, Ashley M., et al.
Publicado: (2019) -
Indirect Estimation of the Comparative Treatment Effect in Pharmacogenomic Subgroups
por: Sorich, Michael J., et al.
Publicado: (2013) -
Pharmacogenomic testing in paediatrics: Clinical implementation strategies
por: Barker, Charlotte I. S., et al.
Publicado: (2022)